NEW YORK (GenomeWeb) – HiberGene Diagnostics said today that it has received CE marking for its HG Flu A/B Combo test and has launched it in Europe, Asia, and South America.
The test uses nasopharyngeal swabs for the direct detection of the influenza virus and provides a differential diagnosis between the A and B subtypes to facilitate best treatment options.